SAREPTA THERAPEUTICS, INC. Proceeds from Issuance or Sale of Equity
SAREPTA THERAPEUTICS, INC. (SRPT) reported Proceeds from Issuance or Sale of Equity of $19.39 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2019-08-07
- SAREPTA THERAPEUTICS, INC. proceeds from issuance or sale of equity for the quarter ending 2019-06-30 was $7.09M, a 67.38% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. proceeds from issuance or sale of equity for the quarter ending 2019-03-31 was $12.30M, a 2.72% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. proceeds from issuance or sale of equity for the quarter ending 2018-12-31 was $7.19M, a 108.74% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. proceeds from issuance or sale of equity for the quarter ending 2018-09-30 was $8.64M, a 12.37% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. proceeds from issuance or sale of equity for fiscal 2018 was $50.22M, a 229.89% increase from fiscal 2017.
- SAREPTA THERAPEUTICS, INC. proceeds from issuance or sale of equity for fiscal 2017 was $15.22M, a 27.26% decline from fiscal 2016.
- SAREPTA THERAPEUTICS, INC. proceeds from issuance or sale of equity for fiscal 2016 was $20.93M, a 84.00% decline from fiscal 2015.
- SAREPTA THERAPEUTICS, INC. proceeds from issuance or sale of equity for fiscal 2015 was $130.81M, a 25.47% increase from fiscal 2014.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 6 month as first filed | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month | Proceeds from Issuance or Sale of Equity 371 month | Proceeds from Issuance or Sale of Equity 374 month | Proceeds from Issuance or Sale of Equity 377 month | Proceeds from Issuance or Sale of Equity 380 month | Proceeds from Issuance or Sale of Equity 383 month | Proceeds from Issuance or Sale of Equity 386 month | Proceeds from Issuance or Sale of Equity 389 month | Proceeds from Issuance or Sale of Equity 392 month | Proceeds from Issuance or Sale of Equity 395 month | Proceeds from Issuance or Sale of Equity 398 month | Proceeds from Issuance or Sale of Equity 401 month | Proceeds from Issuance or Sale of Equity 404 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | $7.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $19.39M 10-Q · filed 2019-08-07 | $26.58M derived: sum of 3 quarters · filed 2019-08-07 | $35.23M derived: sum of 4 quarters · filed 2019-08-07 | |||||||||||||
| 2019-03-31 | $12.30M 10-Q · filed 2019-05-08 | $19.49M derived: sum of 2 quarters · filed 2019-05-08 | $28.14M derived: sum of 3 quarters · filed 2019-05-08 | $49.88M derived: sum of 4 quarters · filed 2019-08-07 | |||||||||||||
| 2018-12-31 | $7.19M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $15.84M derived: sum of 2 quarters · filed 2019-02-28 | $37.58M derived: sum of 3 quarters · filed 2019-08-07 | $50.22M 10-K · filed 2019-02-28 | |||||||||||||
| 2018-09-30 | $8.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $30.39M derived: sum of 2 quarters · filed 2019-08-07 | $43.03M 10-Q · filed 2018-10-31 | $46.48M derived: sum of 4 quarters · filed 2019-08-07 | |||||||||||||
| 2018-06-30 | $21.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $34.39M 10-Q · filed 2019-08-07 | $37.83M derived: sum of 3 quarters · filed 2019-08-07 | $45.52M derived: sum of 4 quarters · filed 2019-08-07 | |||||||||||||
| 2018-03-31 | $12.64M 10-Q · filed 2019-05-08 | $16.09M derived: sum of 2 quarters · filed 2019-05-08 | $23.78M derived: sum of 3 quarters · filed 2019-05-08 | $25.12M derived: sum of 4 quarters · filed 2019-05-08 | |||||||||||||
| 2017-12-31 | $3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $11.14M derived: sum of 2 quarters · filed 2019-02-28 | $12.47M derived: sum of 3 quarters · filed 2019-02-28 | $15.22M 10-K · filed 2019-02-28 | |||||||||||||
| 2017-09-30 | $7.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $9.03M derived: sum of 2 quarters · filed 2018-10-31 | $11.78M 10-Q · filed 2018-10-31 | $21.74M derived: sum of 4 quarters · filed 2019-02-28 | |||||||||||||
| 2017-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $4.09M 10-Q · filed 2018-08-08 | $14.05M derived: sum of 3 quarters · filed 2019-02-28 | $22.84M derived: sum of 4 quarters · filed 2019-02-28 | |||||||||||||
| 2017-03-31 | $2.75M 10-Q · filed 2018-05-03 | $12.71M derived: sum of 2 quarters · filed 2019-02-28 | $21.50M derived: sum of 3 quarters · filed 2019-02-28 | $22.19M derived: sum of 4 quarters · filed 2019-02-28 | |||||||||||||
| 2016-12-31 | $9.96M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $18.75M derived: sum of 2 quarters · filed 2019-02-28 | $19.44M derived: sum of 3 quarters · filed 2019-02-28 | $20.93M 10-K · filed 2019-02-28 | |||||||||||||
| 2016-09-30 | $8.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $9.48M derived: sum of 2 quarters · filed 2017-11-01 | $10.97M 10-Q · filed 2017-11-01 | $136.57M derived: sum of 4 quarters · filed 2017-11-01 | |||||||||||||
| 2016-06-30 | $693.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $2.18M 10-Q · filed 2017-08-03 | $39.68M 10-Q · filed 2016-08-09 | $127.78M derived: sum of 3 quarters · filed 2017-08-03 | $132.01M derived: sum of 4 quarters · filed 2017-08-03 | ||||||||||||
| 2016-03-31 | $1.49M 10-Q · filed 2017-05-04 | $127.09M derived: sum of 2 quarters · filed 2017-05-04 | $131.32M derived: sum of 3 quarters · filed 2017-05-04 | ||||||||||||||
| 2015-12-31 | $125.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $129.83M derived: sum of 2 quarters · filed 2016-11-07 | $130.81M 10-K · filed 2016-02-25 | ||||||||||||||
| 2015-09-30 | $4.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $5.20M 10-Q · filed 2016-11-07 | |||||||||||||||
| 2015-06-30 | $971.00K 10-Q · filed 2016-08-09 | ||||||||||||||||
| 2014-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $5.48M derived: sum of 2 quarters · filed 2016-02-25 | $101.54M derived: sum of 3 quarters · filed 2016-02-25 | $104.25M 10-K · filed 2016-02-25 | |||||||||||||
| 2014-09-30 | $5.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $101.49M derived: sum of 2 quarters · filed 2015-11-05 | $104.20M 10-Q · filed 2015-11-05 | $106.24M derived: sum of 4 quarters · filed 2016-02-25 | |||||||||||||
| 2014-06-30 | $96.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $98.77M 10-Q · filed 2015-08-06 | $100.81M derived: sum of 3 quarters · filed 2016-02-25 | $239.84M derived: sum of 4 quarters · filed 2016-02-25 | |||||||||||||
| 2014-03-31 | $2.71M 10-Q · filed 2014-05-08 | $4.75M derived: sum of 2 quarters · filed 2016-02-25 | $143.78M derived: sum of 3 quarters · filed 2016-02-25 | $145.71M derived: sum of 4 quarters · filed 2016-02-25 | $625.26M 10-Q · filed 2014-05-08 | ||||||||||||
| 2013-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $141.07M derived: sum of 2 quarters · filed 2016-02-25 | $142.99M derived: sum of 3 quarters · filed 2016-02-25 | $145.99M 10-K · filed 2016-02-25 | $622.54M 10-K · filed 2014-03-03 | ||||||||||||
| 2013-09-30 | $139.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $140.96M derived: sum of 2 quarters · filed 2014-11-06 | $143.95M 10-Q · filed 2014-11-06 | $301.23M derived: sum of 4 quarters · filed 2015-02-26 | $620.51M 10-Q · filed 2013-11-12 | ||||||||||||
| 2013-06-30 | $1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $4.92M 10-Q · filed 2014-08-07 | $162.19M derived: sum of 3 quarters · filed 2015-02-26 | $183.59M derived: sum of 4 quarters · filed 2015-02-26 | $481.47M 10-Q · filed 2013-08-08 | ||||||||||||
| 2013-03-31 | $2.99M 10-Q · filed 2014-05-08 | $160.27M derived: sum of 2 quarters · filed 2015-02-26 | $181.67M derived: sum of 3 quarters · filed 2015-02-26 | $181.67M derived: sum of 4 quarters · filed 2015-02-26 | $479.55M 10-Q · filed 2013-05-09 | ||||||||||||
| 2012-12-31 | $157.28M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $178.68M derived: sum of 2 quarters · filed 2015-02-26 | $178.68M derived: sum of 3 quarters · filed 2015-02-26 | $178.68M 10-K · filed 2015-02-26 | $476.56M 10-K · filed 2013-03-15 | ||||||||||||
| 2012-09-30 | $21.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $21.40M derived: sum of 2 quarters · filed 2013-11-12 | $21.41M 10-Q · filed 2013-11-12 | $21.41M derived: sum of 4 quarters · filed 2014-03-03 | $319.28M 10-Q · filed 2012-11-07 | ||||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $1.00K 10-Q · filed 2013-08-08 | $1.00K derived: sum of 3 quarters · filed 2014-03-03 | $33.00K derived: sum of 4 quarters · filed 2014-03-03 | $297.88M 10-Q · filed 2012-08-07 | ||||||||||||
| 2012-03-31 | $1.00K 10-Q · filed 2013-05-09 | $1.00K derived: sum of 2 quarters · filed 2014-03-03 | $33.00K derived: sum of 3 quarters · filed 2014-03-03 | $32.27M derived: sum of 4 quarters · filed 2014-03-03 | $297.88M 10-Q · filed 2012-05-10 | ||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $32.00K derived: sum of 2 quarters · filed 2014-03-03 | $32.26M derived: sum of 3 quarters · filed 2014-03-03 | $32.38M 10-K · filed 2014-03-03 | $297.88M 10-K · filed 2012-03-13 | ||||||||||||
| 2011-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $32.26M derived: sum of 2 quarters · filed 2012-11-07 | $32.38M 10-Q · filed 2012-11-07 | $32.42M derived: sum of 4 quarters · filed 2013-03-15 | $297.88M 10-Q · filed 2011-11-08 | ||||||||||||
| 2011-06-30 | $32.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $32.35M 10-Q · filed 2012-08-07 | $32.38M derived: sum of 3 quarters · filed 2013-03-15 | $34.89M derived: sum of 4 quarters · filed 2013-03-15 | $297.85M 10-Q · filed 2011-08-08 | ||||||||||||
| 2011-03-31 | $116.00K 10-Q · filed 2012-05-10 | $152.00K derived: sum of 2 quarters · filed 2013-03-15 | $2.66M derived: sum of 3 quarters · filed 2013-03-15 | ||||||||||||||
| 2010-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $2.54M derived: sum of 2 quarters · filed 2013-03-15 | $2.56M 10-K · filed 2013-03-15 | ||||||||||||||
| 2010-09-30 | $2.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $2.52M 10-Q · filed 2011-11-08 | |||||||||||||||
| 2010-06-30 | $19.00K 10-Q · filed 2011-08-08 | ||||||||||||||||
| 2009-12-31 | $47.84M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |